Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-001094
Filing Date
2023-01-04
Accepted
2023-01-04 17:08:49
Documents
2
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1566
2 POA DOCUMENT poa.txt EX-24 3610
  Complete submission text file 0001209191-23-001094.txt   6591
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EXICURE, INC. 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address
Hwang Jiyoung (Reporting) CIK: 0001960063 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39011 | Film No.: 23507763